Key third-quarter readouts for big pharma

Key third-quarter readouts for big pharma

Source: 
EP Vantage
snippet: 

Abbvie expects more Rinvoq data in ulcerative colitis while Astrazeneca takes on myasthenia gravis, and gene therapy is in play for Pfizer and Roche.